Shares of The Clorox Company (NYSE:CLX – Get Free Report) have been assigned an average recommendation of “Reduce” from the sixteen research firms that are presently covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a sell recommendation and twelve have given a hold recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $146.43.
CLX has been the subject of several recent research reports. UBS Group reduced their price target on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Wells Fargo & Company reduced their price target on Clorox from $140.00 to $135.00 and set an “underweight” rating for the company in a research report on Thursday, May 2nd. JPMorgan Chase & Co. reduced their price target on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. DA Davidson restated a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a research report on Wednesday, April 17th. Finally, Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective for the company in a research report on Tuesday, March 26th.
Check Out Our Latest Analysis on CLX
Institutional Investors Weigh In On Clorox
Clorox Trading Up 0.2 %
Clorox stock opened at $131.54 on Wednesday. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. Clorox has a 52 week low of $114.68 and a 52 week high of $169.14. The company has a market capitalization of $16.34 billion, a price-to-earnings ratio of 68.16, a price-to-earnings-growth ratio of 2.07 and a beta of 0.44. The stock has a 50-day moving average price of $143.83 and a 200 day moving average price of $144.80.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the previous year, the company posted $1.51 earnings per share. The company’s revenue was down 5.3% compared to the same quarter last year. Sell-side analysts anticipate that Clorox will post 5.83 EPS for the current year.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th were paid a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.65%. The ex-dividend date was Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 248.71%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Dividend Capture Strategy: What You Need to Know
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Manufacturing Stocks Investing
- These 2 Retail Traders Favorites are Nearing Major Breakouts
- Investing in Construction Stocks
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.